Recital 10, Regulation (EU) 2026/1763

In forcesince 13 Jul 2026

As a result of the amendments to Annex III to Delegated Regulation (EU) 2017/583, the references to that Annex in Article 1(a), point (ii), and Articles 3, 4 and 5 of Commission Delegated Regulation (EU) 2017/2194 [Commission Delegated Regulation (EU) 2017/2194 of 14 August 2017 supplementing Regulation (EU) No 600/2014 of the European Parliament and of the Council on markets in financial instruments with regard to package orders (OJ L 312, 28.11.2017, p. 1, ELI: http://data.europa.eu/eli/reg_del/2017/2194/oj).] should be replaced with references specifying the exact scope of asset classes covered by those provisions. Furthermore, Article 2 of Delegated Regulation (EU) 2017/2194 should be aligned with the scope of OTC derivatives subject to transparency requirements pursuant to Article 8a(2) of Regulation (EU) No 600/2014.